메뉴 건너뛰기




Volumn 43, Issue 6, 2009, Pages 1050-1056

Risk perception for developing diabetes among pharmacists

Author keywords

Diabetes mellitus; Pharmacist; Risk perception

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PERCEPTION; PERSONAL MONITORING; PHARMACIST; PRIORITY JOURNAL; RISK FACTOR; RISK PERCEPTION; SELF REPORT;

EID: 67249097452     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L692     Document Type: Article
Times cited : (12)

References (21)
  • 1
    • 67249137131 scopus 로고    scopus 로고
    • accessed 2008 Nov 27
    • Centers for Disease Control and Prevention. www.cdc.gov/diabetes/pubs/ pdf/ndfs-2007.pdf (accessed 2008 Nov 27).
  • 2
    • 43449108812 scopus 로고    scopus 로고
    • Economic costs of diabetes in the United States in 2007
    • American Diabetes Association
    • American Diabetes Association. Economic costs of diabetes in the United States in 2007. Diabetes Care 2008;31:596-615.
    • (2008) Diabetes Care , vol.31 , pp. 596-615
  • 3
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Diabetes Prevention Program Research Group
    • Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
    • (2002) N Engl J Med , vol.346 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.E.3
  • 5
    • 0035799806 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
    • Finnish Diabetes Prevention Study Group
    • Tuomilehto J, Lindstrom J, Eriksson JG, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
    • (2001) N Engl J Med , vol.344 , pp. 1343-1350
    • Tuomilehto, J.1    Lindstrom, J.2    Eriksson, J.G.3
  • 6
    • 0030935652 scopus 로고    scopus 로고
    • Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The DA Qing IGT and Diabetes Study
    • Pan XR, LI GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The DA Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544
    • (1997) Diabetes Care , vol.20 , pp. 537-544
    • Pan, X.R.1    Li, G.W.2    Hu, Y.H.3
  • 7
    • 1042303480 scopus 로고    scopus 로고
    • XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
    • DOI 10.2337/diacare.27.1.155
    • Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-161 (Pubitemid 38196725)
    • (2004) Diabetes Care , vol.27 , Issue.1 , pp. 155-161
    • Torgerson, J.S.1    Hauptman, J.2    Boldrin, M.N.3    Sjostrom, L.4
  • 8
    • 33748748206 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomized controlled trial
    • The DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) Trial Investigators
    • The DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 2006;368:1096-1105
    • (2006) Lancet , vol.368 , pp. 1096-1105
  • 9
    • 0037097039 scopus 로고    scopus 로고
    • Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial
    • DOI 10.1016/S0140-6736(02)08905-5
    • Chiasson JL, Josse RG, Gomis R, Hanefeld M, Daraski A, Laakso M. Acarbose for prevention of type 2 diabetes: the STOP-NIDDM randomized trial. Lancet 2002;359:2072-2077 (Pubitemid 34680970)
    • (2002) Lancet , vol.359 , Issue.9323 , pp. 2072-2077
    • Chiasson, J.-L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 11
    • 0033628661 scopus 로고    scopus 로고
    • How patients with diabetes perceive their risk of major complications
    • Meltzer D, Egleston B. How patients with diabetes perceive their risk of major complications. Eff Clin Pract 2000;3:7-15.
    • (2000) Eff Clin Pract , vol.3 , pp. 7-15
    • Meltzer, D.1    Egleston, B.2
  • 12
    • 67249102146 scopus 로고    scopus 로고
    • accessed 2009 Jan 12
    • American Diabetes Association. www.diabetes.org/risk-test/text-version. jsp (accessed 2009 Jan 12).
  • 13
    • 0041859607 scopus 로고    scopus 로고
    • Risk perception for developing diabetes: Comparative risk judgments of physicians
    • DOI 10.2337/diacare.26.9.2543
    • Walker EA, Mertz CK, Kalten MR, Flynn J. Risk perception for developing diabetes: comparative risk judgments of physicians. Diabetes Care 2003;26:2543-2548 (Pubitemid 37055445)
    • (2003) Diabetes Care , vol.26 , Issue.9 , pp. 2543-2548
    • Walker, E.A.1    Mertz, C.K.2    Kalten, M.R.3    Flynn, J.4
  • 14
    • 24444444660 scopus 로고    scopus 로고
    • Comparative risk judgments among participants in the Diabetes Prevention Program
    • abstract
    • Walker EA, Fisher E, Marrero D, McNabb W. Comparative risk judgments among participants in the Diabetes Prevention Program (abstract). Diabetes 2001;50:A397.
    • (2001) Diabetes , vol.50
    • Walker, E.A.1    Fisher, E.2    Marrero, D.3    McNabb, W.4
  • 15
    • 4243634395 scopus 로고    scopus 로고
    • Evaluating risk perception of developing diabetes as a multi-dimensional construct
    • abstract
    • Walker EA, Wylie-Rosett J. Evaluating risk perception of developing diabetes as a multi-dimensional construct (abstract). Diabetes 1998;47(suppl 1):A5.
    • (1998) Diabetes , vol.47 , Issue.SUPPL. 1
    • Walker, E.A.1    Wylie-Rosett, J.2
  • 17
    • 0021397380 scopus 로고
    • The health belief model: A decade later
    • Janz N, Becker M. The health belief model: a decade later. Health Educ Q 1984;11:1-47.
    • (1984) Health Educ Q , vol.11 , pp. 1-47
    • Janz, N.1    Becker, M.2
  • 18
    • 0023324565 scopus 로고
    • Perception of risk
    • Slovic P. Perception of risk. Science 1987;236:280-285 (Pubitemid 17061043)
    • (1987) Science , vol.236 , Issue.4799 , pp. 280-285
    • Slovic, P.1
  • 20
    • 33846605542 scopus 로고    scopus 로고
    • Measuring comparative risk perceptions in an urban minority population: The risk perception survey for diabetes
    • Walker EA, Caban A, Schechter CB, et al. Measuring comparative risk perceptions in an urban minority population: the risk perception survey for diabetes. Diabetes Educ 2007;33:103-110
    • (2007) Diabetes Educ , vol.33 , pp. 103-110
    • Walker, E.A.1    Caban, A.2    Schechter, C.B.3
  • 21
    • 34548459700 scopus 로고    scopus 로고
    • Risk perception for diabetes among women with histories of gestational diabetes mellitus
    • DOI 10.2337/dc07-0618
    • Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA. Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 2007;30:2281-2286 (Pubitemid 47359032)
    • (2007) Diabetes Care , vol.30 , Issue.9 , pp. 2281-2286
    • Kim, C.1    McEwen, L.N.2    Piette, J.D.3    Goewey, J.4    Ferrara, A.5    Walker, E.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.